JPMAM teams up with UBS Global Wealth Management to launch machine learning fund

Combines machine learning and active equity

James Baxter-Derrington
The Genetic Therapies fund will be co-managed by Yazann Romahi, Berkan Sesen and Ajiaz Hussei

The Genetic Therapies fund will be co-managed by Yazann Romahi, Berkan Sesen and Ajiaz Hussei

J.P. Morgan Asset Management (JPMAM) has launched JP Morgan Funds Genetic Therapies, an actively managed fund, in partnership with UBS Global Wealth Management.

The fund will combine "machine learning and active equity insights" and leverages UBS research from its longer term investments framework. Genetic therapies are at an "inflection point", currently moving...

To continue reading this article...

Join Investment week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week


More on Specialist

Ritu Vohora of T. Rowe Price

From beverage manufacturers to luxury goods: How pricing power trumps inflation

Valuations matter more than before

Ritu Vohora
clock 12 May 2022 • 4 min read
Josh Sambrook-Smith of Sarasin Digital Opportunities

Sarasin to merge away Digital Opportunities fund

Investor focus shifted

clock 03 May 2022 • 2 min read
Investors need to look “beyond a compelling narrative,” according to Kenneth Lamon, senior manager research analyst of passive strategies at Morningstar.

Thematic funds: How pure are they and should they be?

£800bn invested worldwide

clock 28 April 2022 • 6 min read